BM
Bhavin Manharlal Ajmera
About Bhavin Manharlal Ajmera
Data last updated:
Bhavin Manharlal Ajmera has 16 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Vardhman Chemtech Limited and Dpb Pharmaceuticals Limited. Formerly with 3 companies, such as Kinvan Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹432 Cr; the largest is Dpb Pharmaceuticals Limited at ₹223 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dpb Pharmaceuticals Limited U24304MH2018PLC308316 | Director | 20 Apr 2018 | 2018 | ₹223 Cr (FY 2024) | Active |
 Vardhman Chemtech Limited U24117CH1996PLC018656 | Director | 02 Feb 2021 | 1996 | ₹209 Cr (FY 2025) | Active |
 Dpb Antibiotics Private Limited U51397CH2010PTC046352 | Director | 27 Mar 2010 | 2010 | ₹10,000 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Kinvan Private Limited U24100HP2020PTC011851 | Director | 10 Nov 2021 | 2020 | ₹136 Cr (FY 2025) | Active |
| Bodhitree Life Sciences Limited U33119PB2020PLC051477 | Additional Director | 20 Sep 2021 | 2020 | – | Strike Off |
 Parth Antibiotics Private Limited U51397MH2009PTC197201 | Director | 21 Nov 2009 | 2009 | ₹3.13 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavin Manharlal Ajmera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavin Manharlal Ajmera
Bhavin Manharlal Ajmera has 16 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Vardhman Chemtech Limited and Dpb Pharmaceuticals Limited. Formerly with 3 companies, such as Kinvan Private Limited. Engaged in Technology, General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹432 Cr; the largest is Dpb Pharmaceuticals Limited at ₹223 Cr (FY 2024).
Bhavin Manharlal Ajmera is associated with 3 companies as Director and Additional Director, including Dpb Pharmaceuticals Limited (₹223 Cr), Vardhman Chemtech Limited (₹209 Cr), Dpb Antibiotics Private Limited (₹10,000).
Bhavin Manharlal Ajmera has expertise in Technology, General Business.
Bhavin Manharlal Ajmera has 16 years in corporate governance.
By reported revenue, the largest current company of Bhavin Manharlal Ajmera is Dpb Pharmaceuticals Limited, with revenue of ₹223 Cr (FY 2024).
The 3 current companies of Bhavin Manharlal Ajmera that report revenue have a combined latest revenue of ₹432 Cr.
Bhavin Manharlal Ajmera currently holds positions at 3 companies: Dpb Pharmaceuticals Limited (₹223 Cr), Vardhman Chemtech Limited (₹209 Cr), Dpb Antibiotics Private Limited (₹10,000).